Addaven, Infusionskonzentrat
7680651530014
CH-65153
Infusionskonzentrat
Associated product:
ADDAVEN conc perf 20 amp 10 ml
1 / 3
google
Article details
- Package size
- 20 x 10
- Selling units
- 20
- Measure
- ml
- Galenic form
- Infusionskonzentrat
- Galenic group
- Lösbar zur Injektion/Infusion
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
2.0 UMOL | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
7.7 UMOL | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
0.1 UMOL | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
0.6 UMOL | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
0.1 UMOL | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
20.0 NMOL | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
0.1 UMOL | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
0.02 UMOL | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
5.0 UMOL | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.12 MG | Substance | HBESI |
|
(N/A)
|
3.9 UG | Substance | HBESI |
Authorization holder
Fresenius Kabi (Schweiz) AG
6010 Kriens
Authorization information
- Swissmedic authorization number
- 65153
- Drug name
- Addaven, Infusionskonzentrat
- Galenic form
- KOINF
- ATC Code
- B05XA31
- Authorization status
- Z
- Dispensing category
- B
- First authorization
- 10/04/2015
- Authorization expiration date
- 31/12/9999
- IT Number
- 07.01.2.
- Domain
- Human medicine
Package details
- Description (FR)
- ADDAVEN conc perf 20 amp 10 ml
- Description (DE)
- ADDAVEN Inf Konz 20 Amp 10 ml
- Market launch
- 10/04/2015
- Narcotic (BTM)
- No